PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNotices
BuyersSuppliersNotices
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Celltrion Healthcare United Kingdom Limited
CH

Celltrion Healthcare United Kingdom Limited

Uxbridge
Large

Celltrion Healthcare is involved in the global sale of biopharmaceuticals, contributing to improved patient access to healthcare. They supply high-quality biosimilars to over 110 countries through a network of global partners.

celltrionhealthcare.com ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£1.3bn
Live
34
Buyers
7
12m
£1.1bn
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities4
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts34 / 52
  • Top buyers7
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Celltrion Healthcare United Kingdom LimitedUpdated 06 Jul 2026

At a glance · for buyers and watchdogs

Celltrion Healthcare United Kingdom Limited has won £1.3bn across 7 public-sector buyers, with 34 live contracts. No active Companies House risk flags.

Why: top buyer NHS England North East and Yorkshire Health and Justice at 62% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
34 of 52Live contracts
62%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value

Commitments mapped to the Government Social Value Model themes.

⚑ Self-reported
—

No social-value commitments yet

Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Sectors served · 1/8
Central government✓
Local government✓
NHS & health✓
Housing✓
Utilities & energy✓
Financial services✓
Education✓
Defence✓
Services · 1
BiosimilarsCelltrion Healthcare offers a range of biosimilars including Remsima®, Truxima®, and Herzuma® for various medical conditions. ↗
Frameworks & DPS · 4 from notices
  • NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England · £13.3m
  • NHS Framework for the North of England, Branded MedicineNHS England · £7.7m
  • NHS Framework for the NHS London Region, Branded Medicines - Tranche ANHS England · £6.8m
  • NHS Framework Agreement - North of England - Tranche BNHS England · £5.6m

Extracted automatically from celltrionhealthcare.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 34 live · 18 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
NHS National Framework Agreement for Omalizumab
NHS England—01 Feb 2026£87.4m1.6 yrspending
NHS National Framework for the supply of Tocilizumab Injection
NHS England—01 Mar 2026£150.1m1.5 yrspending
Project/Contract NHS National Framework for Denosumab Injection
NHS England—01 Jan 2026£37.7m12 mopending
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025
NHS England North East and Yorkshire Health and Justice—01 Dec 2025£782.9m1.5 yrspending
NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025
NHS England3360000001 Sept 2025£47.0m2 yrsLive
NHS Branded Medicines Tranche Framework for London and South of England
NHS England3360000001 Sept 2024£13.1m2 yrsLive
NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024
NHS England3360000001 Mar 2024£17.6m2.5 yrsLive
NHS South of England Branded Medicines - Tranche A - September 2023
NHS England3360000001 Sept 2023£7.6m2 yrsClosed
NHS London Branded Medicines - Tranche B - September 2023
NHS England3360000001 Sept 2023£6.4m2 yrsClosed
NHS Midland & East Branded Medicines, Tranche B & Annual Tranche
NHS England3360000001 Mar 2023£13.7m2 yrsClosed
Total live value £77.7m · mean award £24.2m1–10 of 52

Top buyers · 7 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS England North East and Yorkshire Health and Justice
1 contract
62%
since 2025
2
NHS England
36 contracts
38%
since 2020
3
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
8 contracts
0%
4
eTenderwales
1 contract
0%
5
The NHS Commissioning Board (operating under the name of NHS England)
4 contracts
0%
6
Northern Health and Social Care Trust NHSCT
1 contract
0%
7
BELFAST HEALTH AND SOCIAL CARE TRUST
1 contract
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Yorkshire37 contracts
100%
Scotland8 contracts
0%
Wales1 contract
0%
North West4 contracts
0%
Northern Ireland2 contracts
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Celltrion Healthcare United Kingdom Limited highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
CH
Celltrion Healthcare United Kingdom Limited
No£1.1bn—
DR
Dr Reddy's Laboratories (UK) Ltd
Yes£121.0m17
JA
Janssen-Cilag Ltd
Yes£117.6m16
AB
AbbVie Ltd
Yes£95.2m11
TA
Thornton and Ross Ltd
Yes£72.5m9
AC
ACCORD-UK LTD
Yes£71.2m18
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 31 Dec 2024
Confirmation statement
Up to date
Next due 02 Dec 2026
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
11685363
Status
Active
Type
Private limited
Incorporated
19 Nov 2018
Reg. office
The Charter Building, Charter Place, Uxbridge, UB8 1JG
SIC codes
46460
Last accounts
31 Dec 2024
Next accounts due
30 Sept 2026

Directors & PSC

  • KIM, Dongsik — director
    Appointed 16 Mar 2023
  • LEE, Hangi — director
    Appointed 19 Nov 2018
  • Jungjin Seo — person with significant control
    ownership of shares 25 to 50 percent · voting rights 25 to 50 percent

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
CELLTRION HEALTHCARE UNITED KINGDOM LIMITED
11685363 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.